The new guidelines, issued by Brazilian medical societies, change the management of thyroid disorders during pregnancy. They state that it is no longer necessary to administer levothyroxine to pregnant women with anti-TPO antibodies but with normal thyroid function. Furthermore, increased monitoring is recommended for cases of elevated TSH levels, especially early in pregnancy, to prevent complications.